ESC CVD Prevention Guidelines 2021: Improvements, Controversies, and Opportunities
The third iteration of the European Society of Cardiology (ESC) cardiovascular disease (CVD) prevention guidelines was recently released at the 2021 ESC Congress. Following on from the original guidelines of 2012 and the update of 2016, these guidelines have been developed by the task force for CVD prevention in clinical practice with representatives of the ESC and 12 medical societies.
These guidelines reiterate the complexity of current knowledge in CVD prevention, and the need to move forward to more digitalized platforms for calculation of risk.
Clinical quantitative coronary artery stenosis and coronary atherosclerosis imaging: a Consensus Statement from the Quantitative Cardiovascular Imaging Study Group
Abstract The detection and characterization of coronary artery stenosis and atherosclerosis using imaging tools are key for clinical decision-making in…
Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy
In these contemporary data from 31 245 patients who are receiving statin therapy, residual inflammatory risk appears to be more…